Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter
2026-08-04 15:31:48Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter Business Standard...
Read MoreBoard Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended 30Th June 2026
31-Jul-2026 | Source : BSEAlembic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2026.
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
13-Jul-2026 | Source : BSEPlease find enclosed herewith a specimen copy of the letter sent to the shareholders of the Company whose email address are not registered with the Company / Depositories providing them a web-link along with the exact path to access the annual report for the F.Y. 2025-26 on the website of the Company.
Announcement under Regulation 30 (LODR)-Newspaper Publication
11-Jul-2026 | Source : BSEPlease find enclosed herewith a copy of the notice published in Indian Express (English Edition) and Financial Express (Gujarati Edition - vernacular language) on 11th July 2026 inter alia informing the members about the schedule of 119th Annual General Meeting of the Company dispatch of Annual Report for F.Y. 2025-26 and procedure for e-voting.
Corporate Actions
(11 Aug 2026)
Alembic Ltd has declared 120% dividend, ex-date: 04 Aug 26
Alembic Ltd has announced 2:10 stock split, ex-date: 26 Sep 06
Alembic Ltd has announced 1:1 bonus issue, ex-date: 27 Sep 13
No Rights history available